Orlistat
| CAS No. | 96829-58-2 | Cat. No. | BCP04653 |
| Name | Orlistat | ||
| Synonyms | Tetrahydrolipstatin;Ro 18-0647; Ro18-0647; Ro-18-0647; Ro 180647; Ro180647; Ro-180647; Ro 18-0647/002; | ||
| Formula | C29H53NO5 | M. Wt | 495.73 |
| Description | Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | FAS | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.